From overtreating good-risk patients to searching for a cure, Adam Kittai, MD, Perlmutter Cancer Center, outlines where CLL ...
Integrin β6 is expressed in ~90% of NSCLC and correlates with poor prognosis, supporting development of a selective, rapidly internalizing ADC designed to reduce off-target integrin binding.
FDA cleared generic rifapentine for active pulmonary TB (≥12 years) with susceptible isolates, requiring combination therapy with other active antitubercular agents. Authorization also covers LTBI (≥2 ...
Abnormal creatinine in CKD can justify SGLT2 inhibitor initiation irrespective of diabetes status, given robust renal and ...
Flatiron Telescope uses AI and transparent SQL to turn real-world evidence into quick turnaround oncology research and ...
RBD is characterized by abnormal REM-related behaviors and experiences, often involving threat-themed dream enactment, and requires polysomnographic documentation of REM-associated motor or vocal ...
Repeatedly assessed resistance training addressed exposure misclassification inherent to single baseline measures, enabling evaluation of long-term patterns across 143,715 participants followed a mean ...
Current sickle cell disease (SCD) trial eligibility criteria exclude most adults, with only 9.9% meeting inclusion thresholds ...
Phase 1 BALLI-01 trial results showed promising UCART22 activity in R/R B-cell ALL, with higher remission rates after a ...
First, the AASM guideline recommends a combination of CBT‑I and medication over medication alone for adults with chronic ...
Historically characterized by excessive daytime sleepiness and cataplexy, narcolepsy is increasingly recognized as a ...
Standardized order sets, clinical team training on toxicity grading and treatment algorithms, and immediate access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results